Hualan Biological Vaccine Inc. (SHE:301207)

Hualan Biological Vaccine Revenue

Hualan Biological Vaccine had revenue of 746.03M CNY in the quarter ending September 30, 2025, a decrease of -19.07%. This brings the company's revenue in the last twelve months to 976.44M, down -40.80% year-over-year. In the year 2024, Hualan Biological Vaccine had annual revenue of 1.13B, down -53.21%.

• Revenue (ttm): 976.44M
• Revenue Growth: -40.80%
• P/S Ratio: 11.49
• Revenue / Employee: 1.31M
• Employees: 748
• Market Cap: 11.22B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.13B	-1.28B	-53.21%
Dec 31, 2023	2.41B	584.79M	32.03%
Jan 1, 2023	1.83B	-4.17M	-0.23%
Jan 1, 2022	1.83B	-596.52M	-24.59%
Dec 31, 2020	2.43B	1.38B	131.30%